Karo Pharma Aktiebolag ("Karo") has today completed the previously announced acquisition of the skin health brand, E45®, from Reckitt for a total consideration of
Net sales of E45® was
"E45 is a unique brand, which is trusted by consumers and represents quality and consistency, and we see compelling opportunities to unlock value and develop the brand via focused activation and a deepened e-commerce presence. We look forward to engaging with our business partners, customers, and consumers to further develop the brand", says
For further information, please contact:
This information is such information that Karo is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication by the contact persons set out above, at 13.30 CET on
About
Forward-looking statements
This news release contains certain forward-looking statements that are based on uncertainty, as they relate to events and depend on circumstances that will occur in the future and which, by their nature, may have an impact on results of operations and the financial condition of
https://news.cision.com/karo-pharma/r/karo-pharma-completes-the-acquisition-of-the-e45--brand-from-reckitt,c3538059
https://mb.cision.com/Main/72/3538059/1558187.pdf
(c) 2022 Cision. All rights reserved., source